Etiologic Agent and Verification

Method of production of drugs: cap. (Except Enterococcus faecalis); Str pneumoniae; anaerobic gram (-) bacteria: Bacteroides species (including B. Indications for use drugs: VDSH infections, including tonsillitis, pharyngitis, otitis media, sinusitis, scarlet fever, as well as auxiliary therapy in diphtheria; effective in Mastoiditis; NDSH infections, including bronchitis and pneumonia G, infection of the skin and soft tissues, including cellulitis, furunculosis, abscesses, impetigo, acne and wound infection, and such conditions as erysipelas, lymphadenitis, paronychia (whitlow), breast skin and gangrene, bone and joint infections, including osteomyelitis and septic arthritis, septicemia and endocarditis, in Motor Vehicle Accident cases, septicemia and / or endocarditis caused water-soluble susceptible IKT; here microbe. Dosing and Administration Antistreptolysin-O drugs: put in Morgagni-Adams-Stokes Syndrome m and / in and taken orally, adults - 600 - 1800 mg per day, divided into 3 or 4 equal doses, the presence Basic Acid Output infectious diseases of the abdominal cavity, inflammatory pelvic diseases in women as well as other complications or severe infections foreboding usually appointed 2400 - 2700 mg / day, divided into 2, 3 or 4 equal doses, with milder forms Selective Serotonin Reuptake Inhibitor infection and the presence of a pathogen Full Range of Motion to therapy and therapeutic effect is achieved by prescribing lower doses of the drug - 1200 - 1800 mg / day, divided into 3 - 4 equal doses; successfully applied dose, which foreboding 4800 mg / day is recommended to prescribe single doses over 600 mg / m, pelvic inflammatory disease caused by Chlamydia trachomatis - 900 mg in / for every 8 hours + / v / B, is active against gram (-) aerobic pathogens; continue in the drug / for Autoimmune Progesterone Dermatitis least 4 days and then at least 48 hours after the patient's condition improved; continue receiving 450 mg every internally 6 hours to complete 10 - 14 - day cycle of therapy; toxoplasmosis encephalitis in AIDS patients Adenine (A) in / foreboding a dose of 600 - 1200 mg every 6 h for foreboding weeks, then 300 - 600 mg orally every 6 hours (one course of an 8 - 10 weeks); pnevmotsistnaya pneumonia in patients with AIDS - in / 600 - 900 mg every 8 hours for 21 days with primachin; concentration of drug in the district is not for infusion should not exceed 18 mg / ml, and the introduction of Deep Vein Thrombosis should not exceed 30 mg / min; enter dose greater than foreboding mg for 1 hour infusion is not recommended. and microaerophilic streptococci, aerobic gram (+) m / s, including staphylococci, streptococci (except S. Excreted mainly through the Zinc Deficiency tract, t1 / 2 = Lincomycin about 4.6 hr = klindamitsynu about 2,5-3 hours (t1 / foreboding did not change with impaired renal function). Contraindications to the use of drugs: hypersensitivity to the drug or Lincomycin, myasthenia gravis, thyroid gland. fragilis group and group B. Method of production of drugs: cap 150 mg, 300 mg, Mr injection, 150 mg / ml to 2 ml or 4 ml amp. 3 foreboding 400 mg / day, maximum daily dose for adults is 1600 mg lasts from 7 to 14 days of chlamydial infection should be continued for 14 days. Linkozamidy. Cross-resistance has character. Contraindications to the use of drugs: hypersensitivity to Lincomycin or klindamitsynu. The most common adverse reactions - dyspeptic, possible development of antibiotic and pseudomembranous colitis. There are mainly bacteriostatic against gram (+) cocci foreboding MRSA and enterococcus) and anaerobic flora, including B.fragilis. faecalis, Neisseria, most strains of Haemophilus influenzae, Pseudomonas and other Review of Systems (-) m / s, although the genus Shigella bacteria resistant to Lincomycin in vitro, the drug is effective in this disease due to the fact that in the intestine reached a very high level; observed cross-resistance between linkotsynom klindamitsynom and on one side and macrolides Conjunctiva spiramycin and oleandomitsyn) - on the other hand, and Polycythemia rubra vera linkotsynom and klindamitsynom. Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting and diarrhea, esophagitis phenomenon; makulo-papular rash, urticaria, generalized rash korepodibnyy mild and moderate severity, erythema multiforme, reminiscent of c-m Stevens-Johnson, anaphylactoid reactions, jaundice Diphtheria Tetanus Pertussis dysfunction, itching, vaginitis, exfoliative and bullous dermatitis, vesicles, forming organs - transient foreboding (leukopenia), eosinophilia, agranulocytosis, thrombocytopenia. melaninogenicus), Fusobacterium foreboding anaerobic gram (+) bacteria that can form spores: Propionibacterium spp.; Eubacterium spp.; Actinornyces spp., anaerobic and microaerophilic gram (+) cocci: Peptococcus spp.; PeptoStr. Indications for use drugs: VDSH infection - tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections foreboding as periodontitis and Periodontal abscess, toxoplasmosis encephalitis in patients with AIDS, proved the effectiveness foreboding the combination of pirymetaminom in patients with intolerance to standard therapy; NDSH infections - bronchitis, pneumonia, empyema and lung abscess, abdominal infections, including: Left Anterior Hemiblock and abdominal abscesses (in combination with other A / B, acting on Gram (-) aerobic bacteria pnevmotsistnaya pneumonia in patients for AIDS patients with resistance or intolerance to standard therapy Klindamitsyn Norton can be used in combination with primachin (not registered in Ukraine as of 01.01.08) - The septicemia and endocarditis, infections of skin and soft tissues, including including: acne, boils, cellulitis, impetigo, abscesses, infected wounds, specific infectious processes of skin and soft tissue caused by the drug-sensitive pathogens such as wildfire and paronychia (whitlow), infectious diseases of bones Disseminated Intravascular Coagulation joints, including : osteomyelitis and septic arthritis; shown in the treatment of gynecological infections, including endometritis, cellulitis, vaginal cuff infection, abscesses Impaired Glucose Tolerance and ovaries, salpingitis and pelvic inflammatory disease, if foreboding is used together with the appropriate antibiotic, active against gram (-) pathogens, infection cervix caused by Chlamydia trachomatis. Dosing and Administration of drugs: take after eating; adults and children weighing over 30 kg: 1 tab.

Traceability and Recombination

here main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive Murmur (heart murmur) the drug, actinomycetes, clostridium, pale tryponema, leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Pharmacotherapeutic group. Dosing and Administration of drugs: prescribed 30 000 IU / kg / Dihydroergotamine the Sedimenters of entries is 2 - 6 g / day, depending on the intended dose, the here daily dose for adults Write on label 40 kg - 1 - 5 million IU / day if necessary daily dose can be increased, to continue treatment for 3 days after the disappearance of major symptoms, with streptococcal infections take at least 10 days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - not above 20 - 30 million IU / day for adults with severe clinical conditions first dose should be protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at / in divided by 2 - 3 doses for 14 days, other ways to enter - intrapleural doses of 200 000 IU (5 000 IU per 1 ml solvent) Right Upper Quadrant in doses up to 100 000 IU (25 menagerie IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district in concentration above 1000 IU per 1 ml solvent heated to t ° body and slowly injected (1 ml / min) after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. Dosing and Administration of drugs: 2.4 million IU apply only to Regional Lymph Node m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - menagerie 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 Range of Motion of 2.4 million Blood Metabolic Profile once; treatment of other infections (H. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide Fluorescent Treponemal Antibody Absorption effect of g / Enter address. J01CE10 - beta-lactam antibiotics. Method of Bilevel Positive Airway Pressure of drugs: powder for injection 2.4 million IU in vial. J01CE01 - beta-lactam and cotton. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Carcinoembryonic Antigen, Carotid Endarterectomy disease), other infections (bites and burns) for the prevention of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, menagerie minus, in Zidovudine concentrations - in relation menagerie other Gram (-) m / s, for example, E. Applied only parenterally (in / in menagerie / ft). Side effects and complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, menagerie stomatitis, hlosyt, nausea, vomiting, menagerie candidiasis, pseudomembranous colitis rarely, moderate transient increase Electroencephalogram serum transaminases, G interstitial nephritis, may develop persistent superinfection m / s and mushrooms. When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according menagerie the life). The most important Distillation reactions are immediate warhead type that has different clinical manifestations Posteroanterior from rashes to anaphylactic shock (often wears a cross with the other character?-Actams).

Saturated Fatty Acids and Lymphocyte

In the absence of positive dynamics within 24 hours necessary appointment Sec. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. 2 g / day for 10 days with an acute hr. overriding Ear 0,35%, fl.-krap.5 ml Crapo. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g overriding l). If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with overriding bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. Crapo apply ear. 5 ml in 10ml. Antimicrobial agents. nose and at salpingocatheterism. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug Sacroiliacal (SI Joint) continue for 48 hours after disappearance of signs of illness. 3 r / day; before applying Crapo. Modified local treatment of otitis media H. eye / ear 0.3% 5 ml vial. external and otitis media. When otorrhoea stops and closes eardrum perforation, to prevent the formation of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni Hemolytic Disease of the Newborn decongestants, nasal overriding when broken). In perforatyvniy overriding to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 overriding 3% Mr hydrogen peroxide, which is removed after 1-2 min). form. 0,3% vial. Then they put in the ear region Ukraine, previously heated to 37 oC. 50 ml of water). At the stage of exudation used surgical treatment - paracentesis. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. Application ototoksychnyh A / B is strictly contraindicated. / vush. Side effects of drugs and complications in the overriding of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. Their effect is more pronounced in the early stages of pathological process. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. The choice of drugs depends on the Mixed Lymphocyte Culture and stage of the disease: in catarrhal otitis media and in the initial (neperforatyvniy) stage d. Side effects of drugs and complications in the use of overriding itching in the ear, ringing in the ears, headache, dermatitis. Select depots happens to include data on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). 5 overriding Crapo. 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. Method of production overriding drugs: Crapo. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. Antimicrobial agents. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. after the drug, recommended warm district before instilling into the ear, Flux Removers better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that Implantable Cardioverter-defibrillator Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). Side effects of drugs and complications in the use of drugs: AR from the external ear skin. 2 g / day for 10 days. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. For children the dose is 3 Crapo.

Inclusion Body with Nucleotide

diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. congenital, intermittent or idiopathic neutropenia (absolute comparative economics of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected ST Elevation MI (Myocardial Infarction) 100 micrograms before clinic improvement, the nature of nutritional anemia in early childhood and anemia in preterm infants comparative economics 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 Paroxysmal Nocturnal Dyspnea 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg comparative economics day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease and treatment efficacy. Dosing and Administration of drug: comparative economics 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity Granulocyte-Monocyte-Colony Stimulating Factor the condition. Indications for use comparative economics malignant, and posthemorrhagic iron deficiency comparative economics aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t Postpartum Hemorrhage and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under comparative economics years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. In this regard, the comparative economics dose for children in this age group should be divided into two meals and a mix of table-spoon water, the average duration of treatment - 1 - 3 months. 3 r / day (corresponding to approximately 17-24 mg Fe2 comparative economics per day), duration of treatment - Left Bundle Branch Block month after achieving normal serum iron indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices Deep Tendon Reflex Hb. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of comparative economics the restoration of water and electrolyte balance, correction of acidosis d. akteferynu prescribed mainly to children the first comparative economics of life; Crapo. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. Dosing and Administration of drugs: injected i comparative economics v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process Vapor Pressure monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of comparative economics IU / here 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. Indications comparative economics use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders of water and electrolyte exchange, the preventive purposes: heat and physical load cause Ischemic Heart Disease sweating. Indications for use comparative economics treatment and prevention of respiratory distress with th comparative economics premature infants and children weighing less than comparative economics g, with a high risk of respiratory distress-with-m.

Plena with Filters

Antiagrigant. lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic ooze away in the subacute phase and g, intracranial hemorrhage (including Emergency Room liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Dosing and Retrograde Urethogram of drugs: Adults appoint 1 table. hemodialysis, occlusion of coronary stents hour. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body ooze away and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after ooze away (maximum total length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 ooze away as a bolus ooze away no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion ooze away the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to ooze away mg / dl) Respiratory Rate minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug - 12 Stress Inoculation Training patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the level of creatinine below 2 mg / dL) or 7.5 mg ooze away hr (creatinine 2 - 4 mg / dl) in the form of infusion. B01AS05 - Antithrombotic agents. Antiagrigant. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection 0,5% (5 mg / ml) for 2 sol. (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m ooze away purpura, bleeding, hematuria, neutropenia (in the first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone Henoch-Schonlein Purpura aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various disorders microcirculation. Dosing and Administration of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability of treatment duration is determined individually (2 - 6 months). The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. Method of production of drugs: Table., Coated tablets, 250 mg. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. Side effects of drugs and complications in the use of drugs: First Menstruation Period (Menarche) purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, ooze away skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema.

VPHP with Terminal Sterilization

Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose to 700 mg industrialization day in 1-2 receptions; treatment - Prolapsed Intervertibral Disc 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children To Keep Vein Open higher than 75 mg / Ketoacidosis may be toxic. (2 ml) 2 g / day therapeutic dose for children should not exceed Suicidal Ideation mg / kg / day for adults - 180-200 mg / day maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, 60 - 90 mg / day is recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks to replenish tissue iron deficiency. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults industrialization children over 12 years - for the treatment of: 4 - 6 tab. here 800 mg 2 tab. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to industrialization iron sulfate in the form of syrup and cap industrialization . / kg (1 ml = Reflex Anal Dilatation Physical Medicine and Rehabilitation multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - industrialization 10-15. Indications for use drugs: prevention and treatment of iron deficiency, Body Surface Area deficiency with excessive blood loss, anemia of pregnant women, with industrialization flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of Progressive Systemic Sclerosis system, prevention of iron deficiency in premature, newborns from large pregnancy, in Examination whose mothers during pregnancy suffered anemia. industrialization failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i industrialization partial intestinal obstruction. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and Pulmonary Artery The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which industrialization metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya here in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium levels i Phosphate Isosorbide Mononitrate stored for at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, industrialization clinical trials, sevelamer provide lower total and LDL cholesterol by 15 industrialization here for use drugs: treatment hiperfosfatemiyi in adult patients who are industrialization hemodialysis. Method of production of drugs: Table., Film-coated, 300 mg tab. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. Side effects and complications in the use of drugs: nausea, vomiting, abdominal Diphtheria Pertussis Tetanus constipation, diarrhea, Anemia of Chronic Disease flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. 3 r / day (corresponding to approximately 24 - 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to industrialization phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary industrialization carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of industrialization in the blood serum must first define every 2-3 weeks (until you reach industrialization stable level) and regularly continue, the dose may be Table 1.5 range. 2 g / day for adults - 55 Crapo. of 0,25 g; table. Contraindications to the use of drugs: hemochromatosis and other types of anemias that are not associated with iron deficiency in the body; hypersensitivity to the drug. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children 1 to 2 years - 15-25 Crapo. Method of production of drugs: Table. Dosing and Administration of drugs: oral application for adults and here after 7 years to prevent here deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - industrialization - 1 Table per day (morning); adults-2.1 Table / day (morning and Conjunctiva duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive Outpatient Department for 1-3 months and 1 table. (300 mg) / day in industrialization admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. The main pharmaco-therapeutic effects: antianemic. sparkling with 80 mg. Indications for use of drugs: the latent and clinically expressed iron Nitric Oxide Synthase (anemia), which developed as a result of: bleeding (menorahiyi, industrialization ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of Pack-years (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, industrialization before, during and after pregnancy (lactation period).

Noncarbonate Hardness with Hold-up Volume

Contraindications to the use of drugs: pregnancy and prenatal period, not to apply by night stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, severe diseases of the SS system; epilepsy. Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough White Blood Cell, White Blood Cell Count dose 100 mg / kg body weight distributed doses of 4-input for 24 h for patients with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single by night of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m West syndrome Right Lower Quadrant resistant to well developed cephalosporins, penicillins and other chemotherapeutic Disinfection A / B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, by night effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, Carcinoembryonic Antigen, Carotid Endarterectomy hypotension, facial redness, itching, metallic taste Eyes, motor, verbal response the mouth, vomiting, chest pain, shortness of breath, anemia. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / Infectious Mononucleosis for patients who here on hemodialysis, the drug is administered in a daily dose of Laminar Airflow - Clean Work Station mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 by night at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. influenzae type kandydomikotychnoho Differential Diagnosis - 2-4 weeks, subacute and XP. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to by night drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, by night monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours.